These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34196706)

  • 21. Dose Distribution Degradation of Carbon-ion Radiotherapy Caused by Tumor Cell-specific Relative Biological Effectiveness of Osteosarcoma: A Simulation Study Using
    Shiba S; Kawashima M; Okamoto M; Ohno T
    Anticancer Res; 2023 Nov; 43(11):4873-4878. PubMed ID: 37909964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions.
    Toda Y; Kohashi K; Yamada Y; Yoshimoto M; Ishihara S; Ito Y; Iwasaki T; Yamamoto H; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2607-2620. PubMed ID: 32388585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparable Senescence Induction in Three-dimensional Human Cartilage Model by Exposure to Therapeutic Doses of X-rays or C-ions.
    Hamdi DH; Chevalier F; Groetz JE; Durantel F; Thuret JY; Mann C; Saintigny Y
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):139-146. PubMed ID: 27084635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.
    Moon JW; Kong SK; Kim BS; Kim HJ; Lim H; Noh K; Kim Y; Choi JW; Lee JH; Kim YS
    Sci Rep; 2017 Dec; 7(1):17810. PubMed ID: 29259270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of the immune responses in cancer cells irradiated with X-ray, proton and carbon-ion beams.
    Du J; Kageyama SI; Hirata H; Motegi A; Nakamura M; Hirano Y; Okumura M; Yamashita R; Tsuchihara K; Hojo H; Hirayama R; Akimoto T
    Biochem Biophys Res Commun; 2021 Dec; 585():55-60. PubMed ID: 34784552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Chen M; Pockaj B; Andreozzi M; Barrett MT; Krishna S; Eaton S; Niu R; Anderson KS
    Clin Breast Cancer; 2018 Oct; 18(5):e1205-e1215. PubMed ID: 29933930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma.
    Song X; Shao Y; Jiang T; Ding Y; Xu B; Zheng X; Wang Q; Chen X; Gu W; Wu C; Jiang J
    EBioMedicine; 2018 Feb; 28():105-113. PubMed ID: 29396299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.
    Martinkova L; Zatloukalova P; Kucerikova M; Friedlova N; Tylichova Z; Zavadil-Kokas F; Hupp TR; Coates PJ; Vojtesek B
    Cell Mol Biol Lett; 2024 Sep; 29(1):117. PubMed ID: 39237877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy.
    Tu X; Qin B; Zhang Y; Zhang C; Kahila M; Nowsheen S; Yin P; Yuan J; Pei H; Li H; Yu J; Song Z; Zhou Q; Zhao F; Liu J; Zhang C; Dong H; Mutter RW; Lou Z
    Mol Cell; 2019 Jun; 74(6):1215-1226.e4. PubMed ID: 31053471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRP8 activates STAT3 to induce PD-L1 expression in osteosarcoma.
    Zheng S; Wei Y; Jiang Y; Hao Y
    Tumori; 2021 Jun; 107(3):238-246. PubMed ID: 33054597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complexity of DNA double strand breaks is a critical factor enhancing end-resection.
    Yajima H; Fujisawa H; Nakajima NI; Hirakawa H; Jeggo PA; Okayasu R; Fujimori A
    DNA Repair (Amst); 2013 Nov; 12(11):936-46. PubMed ID: 24041488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.
    Xiao G; Jin LL; Liu CQ; Wang YC; Meng YM; Zhou ZG; Chen J; Yu XJ; Zhang YJ; Xu J; Zheng L
    J Immunother Cancer; 2019 Nov; 7(1):300. PubMed ID: 31727135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of PD-L1 Surface Expression on Leukemia Cells with the Ratio of PD-L1 mRNA Variants and with Electrophoretic Mobility.
    Brodská B; Otevřelová P; Kuželová K
    Cancer Immunol Res; 2016 Oct; 4(10):815-819. PubMed ID: 27543594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway.
    Gao Y; Li Y; Lin Z; Zeng Y; Huang Z; Han L; Zhong Y; Gong Y; Wu Q; Xie C
    Immunology; 2023 Feb; 168(2):346-361. PubMed ID: 36326481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AT cells show dissimilar hypersensitivity to heavy-ion and X-rays irradiation.
    Kitajima S; Nakamura H; Adachi M; Ijichi K; Yasui Y; Saito N; Suzuki M; Kurita K; Ishizaki K
    J Radiat Res; 2010; 51(3):251-5. PubMed ID: 20197645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells.
    Kamlah F; Hänze J; Arenz A; Seay U; Hasan D; Juricko J; Bischoff B; Gottschald OR; Fournier C; Taucher-Scholz G; Scholz M; Seeger W; Engenhart-Cabillic R; Rose F
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1541-9. PubMed ID: 21621345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.
    Noh H; Hu J; Wang X; Xia X; Satelli A; Li S
    Cell Commun Signal; 2015 Feb; 13():14. PubMed ID: 25889536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis.
    Gao K; Shi Q; Gu Y; Yang W; He Y; Lv Z; Ding Y; Cao W; Wang C; Wan X
    Cell Death Differ; 2023 Feb; 30(2):475-487. PubMed ID: 36481790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation.
    Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M
    Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.